🇺🇸 FDA

Intelligence Platform

Patents

Browse 94 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7374776

Bone-filling composition for stimulating bone-forming and bone-consolidation comprising ca

REGENBiotech, Inc. · Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7342120

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7256212

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7189861

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7161012

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7151183

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7144916

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7122681

Desolvation process for the production of atorvastatin hemi-calcium essentially free of bo

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7101909

Calcium channel drugs and uses

Theravance, Inc. · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6992194

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6979724

Calcium channel proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6897305

Calcium channel drugs and uses

Theravance, Inc. · Granted Tue May 24 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6653100

hKCa3/KCNN3 small conductance calcium activated potassium channel: A diagnostic marker and

The Regents of the University of California · Granted Tue Nov 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6605636

Atorvastatin hemi-calcium form VII

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 12 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6528661

Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phen

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6444446

Calcium binding proteolipid compositions and methods

The Board of Regents of the University of Texas System · Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6441156

Calcium channel compositions and methods of use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6287607

Potassium calcium citrate compositions and methods therefor

The Board of Regents of the University of Texas System · Granted Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6221861

Reducing pyrophosphate deposition with calcium antagonists

The Regents of the University of California · Granted Tue Apr 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6165719

hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and

The Regents of the University of California · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6106856

Transdermal delivery of calcium channel blockers, such as nifedipine

Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Tue Aug 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6057346

Inhibition of retroviral LTR promoters by calcium response modifiers

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired